Ivacaftor for treating cystic fibrosis with mutations in the CFTR gene in babies and children aged 1 to 3 months or weighing 3 kg to 24 kg [TSID11894]

Status:

Topic selection

Technology type:

Medicine

Decision:

Not selected

Reason for decision:

Not eligible for Health Technology Evaluation guidance

Further information:

Decision makers agreed that a Technology Appraisal (TA) would not be appropriate for the subject technology due to the commissioning arrangements being covered in the existing NHS England policy.

ID number:

11894

Project Team

Project lead

Abbie Stephens

Email enquiries

If you have any queries please email [email protected]

For further information on how we select topics for development, please see our page about prioritising our guidance topics